Activation of anti-tumor immune response and reduction of regulatory T cells with Mycobacterium indicus pranii (MIP) therapy in tumor bearing mice.
BACKGROUND: Role of immune system in protecting the host from cancer is well established. Growing cancer however subverts immune response towards Th2 type and escape from antitumor mechanism of the host. Activation of both innate and Th1 type response is crucial for host antitumor activity. In our p...
Main Authors: | Faiz Ahmad, Jiju Mani, Pawan Kumar, Seenu Haridas, Pramod Upadhyay, Sangeeta Bhaskar |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3184142?pdf=render |
Similar Items
-
Mycobacterium indicus pranii therapy induces tumor regression in MyD88- and TLR2-dependent manner
by: Pawan Kumar, et al.
Published: (2019-10-01) -
Autophagy induction by Mycobacterium indicus pranii promotes Mycobacterium tuberculosis clearance from RAW 264.7 macrophages.
by: Bindu Singh, et al.
Published: (2017-01-01) -
Lipoarabinomannan from Mycobacterium indicus pranii shows immunostimulatory activity and induces autophagy in macrophages.
by: Bindu Singh, et al.
Published: (2019-01-01) -
Efficacy of Mycobacterium indicus pranii immunotherapy as an adjunct to chemotherapy for tuberculosis and underlying immune responses in the lung.
by: Ankan Gupta, et al.
Published: (2012-01-01) -
Mycobacterium indicus pranii Induced Memory T-Cells in Lung Airways Are Sentinels for Improved Protection Against M.tb Infection
by: Ananya Gupta, et al.
Published: (2019-10-01)